Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Dimethylformamide → 1,2,3,4-Tetrahydro-6-[2-(hydroxymethyl)-1H-benzimidazol-1-ylmethyl]-3-methyl-1-(isobutyl)-2,4-dioxothieno[2,3-d]pyrimidine-5-carboxylic acid, methyl ester
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Dimethylformamide | HCID 6228 | — |
| 반응물 | Potassium Carbonate | HCID 11430 | — |
| 반응물 | 2-(Hydroxymethyl)-1H-benzimidazole | HCID 78569 | — |
| 반응물 | 6-[(4,5-Dichloro-2-methyl-1H-imidazol-1-yl)methyl]-5-[4-(S)-hydroxy-2-isoxazolidinylcarbonyl]-3-methyl-1-(isobutyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione | HCID 10142559 | — |
| 생성물 | 1,2,3,4-Tetrahydro-6-[2-(hydroxymethyl)-1H-benzimidazol-1-ylmethyl]-3-methyl-1-(isobutyl)-2,4-dioxothieno[2,3-d]pyrimidine-5-carboxylic acid, methyl ester | HCID 86760682 | — |
반응 단계
The product of example 3 part b) (0.6 g,) was dissolved in DMF (5 ml). 2-Hydroxymethyl-benzimidazole (0.28 g,) and anhydrous potassium carbonate (0.6 g) were added to the solution, which was stirred for 16 h. The sub-title compound was obtained as a white solid after filtration of the reaction mixture and evaporation (0.18 g). MS (APCI) 457 [M+H]+. δ 1HCDCl3 0.87 (3H,s), 0.9 (3H,s), 2.1-2.2 (m, 1H), 3.38 (s,3H), 3.57-3.64 (m,3H), 3.96 (s,3H), 4.97 (s,2H), 5.64 (s,2H), 7.26-7.38 (m,2H), 7.22-7.3 (m,1H) and 7.74-7.8 (m,1H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07384950B2 |
| 출처 데이터셋 | uspto-grants-2008_06 |
| ORD ID | ord-8ce2a44baf4c4238a7f1a5e25c79a9f7 |
| 출처 메모 | uspto-grants-2008_06 |